NOTES PAYABLE (Details Narrative) - USD ($)			1 Months Ended	3 Months Ended		9 Months Ended
NOTES PAYABLE (Details Narrative) - USD ($)	Aug. 18, 2022	Jun. 30, 2019	Jun. 30, 2019	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Aug. 31, 2022	Mar. 13, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Proceeds from notes payable							$ 243,275
Notes payable to shareholders				$ 1,000,000		1,000,000				$ 1,000,000
Amortization of debt discount				$ 42,826	$ 116,178	$ 200,900	$ 297,325
Measurement Input, Expected Term [Member]
Short-Term Debt [Line Items]
Warrants term				2 years		2 years
Measurement Input, Option Volatility [Member]
Short-Term Debt [Line Items]
Warrant measurement inputs				146.4		146.4
Measurement Input, Expected Dividend Payment [Member]
Short-Term Debt [Line Items]
Warrant measurement inputs				0		0
Measurement Input, Risk Free Interest Rate [Member]
Short-Term Debt [Line Items]
Warrant measurement inputs				2.5		2.5
Note Exchange Agreement [Member] \| Promissory Notes [Member]
Short-Term Debt [Line Items]
Debt conversion converted instrument shares						475,688
Principal amount				$ 30,000		$ 30,000
Debt principal accrued interest						$ 8,055
Number of warrants issued				1,902,752		1,902,752
Warrant exercise price				$ 0.08		$ 0.08
Warrants term				2 years		2 years
Warrants and rights outstanding				$ 114,165		$ 114,165
Verbal Agreement [Member]
Short-Term Debt [Line Items]
Advance from third party								$ 30,000
Investment Agreement [Member]
Short-Term Debt [Line Items]
Debt conversion converted instrument shares	475,688
Principal amount									$ 30,000
Debt principal accrued interest	$ 38,055
Minimum [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Short-Term Debt [Line Items]
Warrant measurement inputs				3.48		3.48
Maximum [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Short-Term Debt [Line Items]
Warrant measurement inputs				3.58		3.58
Multiple Short Term Promissory Notes Payable [Member]
Short-Term Debt [Line Items]
Proceeds from notes payable						$ 414,010
Debt instrument, maturity date, description						due dates in March through May 2024
Original issue of discount				$ 31,681		$ 31,681
Multiple Short Term Promissory Notes Payable [Member] \| Minimum [Member]
Short-Term Debt [Line Items]
Debt instrument interest rate				10.00%		10.00%
Multiple Short Term Promissory Notes Payable [Member] \| Maximum [Member]
Short-Term Debt [Line Items]
Debt instrument interest rate				22.00%		22.00%
Secured Convertible 5.75% Promissory Note Payable [Member] \| Investment Agreement [Member]
Short-Term Debt [Line Items]
Debt instrument interest rate		5.75%	5.75%
Notes payable to shareholders		$ 1,000,000	$ 1,000,000
Debt instrument Increased interest rate			10.00%
Debt description		Included in the Investment Agreement is a royalty agreement whereby the investor received 500,000 shares of the Company’s common stock and will be entitled to a royalty of 8.5% from the revenue generated from the “collateral processors” while the principal is outstanding and 5% thereafter on the first two collateral processors for a period of 10 years

NUTRALIFE BIOSCIENCES, INC 10-Q